CNS Pharmaceuticals, Inc. Non Peo Neo Avg Total Comp Amt
CNS Pharmaceuticals, Inc. (CNSP) reported Non Peo Neo Avg Total Comp Amt of $724.81 thousand for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-08-21.
Financial Statements › Notes
ecd:NonPeoNeoAvgTotalCompAmt · last filed 2026-08-21
| Period end | Non Peo Neo Avg Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $724.81K DEF 14A · filed 2026-08-21 |
| 2024-12-31 | $982.69K DEF 14A · filed 2026-08-21 |
| 2023-12-31 | $671.67K DEF 14A · filed 2026-08-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |